Cian Healthcare IPO description – Cian Healthcare develops, manufactures and commercializes pharmaceutical products under 12 therapeutic segments like Orthopaedics, Gynaecology, Paediatrics, Cardiac, Diabetic, Dermatology, Pain Management, Antibiotics, Neuro, Critical Care, Gastro-Intestinal and Nutraceuticals, alongwith 10 sales division focused on developing and growing engagements in specialist and super specialist division. The company works under different business models like Brand Business, Export, Third Party Manufacturing and Government Supplies.
Cian Healthcare has special licence for manufacturing veterinary products for client like SAVAvet and Venky’s. It has developed more than 1,000 formulations and 2000 brands for domestic market. The company is a WHO-GMP & ISO-9001:2015 certified transnational manufacturing Company with wide range of Pharmaceutical, Nutraceutical, Ayurvedic, Cosmeceuticals, Sexual Wellness and Food supplement products.
Cian Healthcare promoters – Suraj Zanwar & Kavita Zanwar
| Cian Healthcare – Upcoming IPO details | |
| Subscription Dates | 2 – 9 May 2019 |
| IPO Price band | INR59 – 65 per share |
| Fresh issue | 6,216,000 shares (INR37.92 – 40.4 crore) |
| Offer for sale | Nil |
| Total IPO size | 6,216,000 shares (INR37.92 – 40.4 crore) |
| Minimum bid (lot size) | 2,000 shares |
| Face Value | INR10 per share |
| Retail Allocation | 50% |
| Listing On | BSE SME platform |
Use of funds
- Upgradation of existing plant i.e. Unit 1 situated at Roorkee, Uttarakhand, India – INR3.50 crore
- Margin Money for Setting up of manufacturing facility i.e. Unit 2 situated at Roorkee, Uttarakhand, India – INR7.28 crore
- Enhancement of company’s brand through advertising and other brand-building activities – INR1.50 crore
- Working Capital Requirements – INR10.00 crore
- Acquisitions and other strategic initiatives – INR7.09 crore
- General Corporate Purposes
- Issue Expenses
| Cian Healthcare’s financial performance (in INR crore) | ||||||
| FY2016 | FY2017 | FY2018 | 9M FY2019 | |||
| Total revenue | 47.16 | 51.85 | 59.59 | 44.48 | ||
| Total expenses | 45.00 | 48.77 | 54.46 | 37.23 | ||
| Profit after tax | 1.37 | 2.24 | 3.76 | 5.25 | ||
Cian Healthcare Contact Details
Cian Healthcare LimitedÂMilkat No. 3339, Block No.1, From South Side
C.S.No.227 /2 + 3A, Harpale Park, Opp Berger Paint
Phursungi, Pune- 412308 Phone:Â +91 020 41471234
Email: [email protected]
Website:Â www.cian.co
Cian Healthcare IPO Subscription Details
| Day |
Subscription (no. of times) |
| Day 1 |
0.03 |
| Day 2 |
0.08 |
| Day 3 |
0.20 |
| Day 4 |
0.28 |
| Day 5 |
0.31 |
| Day 6 |
0.36 |
| Day 7 | 0.36 |
| Day 8 | 0.36 |
| Day 9 | 0.44 |
| Day 10 | 1.18 |
Â
Cian Healthcare Valuation (For FY2018)
Earnings Per Share (EPS): INR2.22
Price/Earnings (P/E) ratio: 27.47 – 29.27
Return on Net Worth (RONW): 22.36%
Net Asset Value (NAV): INR10.00 per share
Registrar of Cian Healthcare IPO
Bigshare Services Private LimitedÂE2, Ansa Industrial Estate, Sakivihar Road,
Sakinaka, Andheri (E)
Mumbai – 400 072 Phone: +91 22 4043 0200Â
Fax:Â +91 22Â 2847Â 5201
Email:Â [email protected]
Website:Â www.bigshareonline.com
Cian Healthcare IPO Allotment Status
Cian Healthcare IPO allotment status is now available on Bigshare Services’ website. Click on this link to get allotment status.
Listing performance of Cian Healthcare
IPO Opening Date: 2 May 2019
IPO Closing Date: 15 May 2019
Listing Date: 23 May 2019
Listing Price on BSE SME: INR62 per share (up 1.64% from IPO price)
Closing Price on BSE SME: INR61.5 per share (up 0.82% from IPO price)
